Delivery Order SPE2DB22D1202-SPE2DB25FUZD3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Fulphila 6 mg/0.6 ml syringes valued at $6,205.73, with completion expected by July 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery under AmerisourceBergen's larger federal...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Fulphila 6 mg/0.6 mL syringes with a ceiling value of $17,539.50 under firm fixed pricing. The order is scheduled for completion by September 15, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $5,314.82 to AmerisourceBergen Drug Corp for Fulphila 6 mg/0.6 mL syringes on September 4, 2025, with completion scheduled for September 5, 2025. This delivery order operates under a firm fixed price structure with no set-aside designation, indicating open competitive award. The pharmaceutical product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Fulphila 6 mg/0.6 mL syringes. The contract has a ceiling value of $14,031.60 and a firm fixed price structure with an ultimate completion date of July 1, 2025. This award was not designated as a set-aside contract and represents a competitively awarded delivery order. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $6,978.73 to AmerisourceBergen Drug Corp for Fulphila 6 mg/0.6 mL syringes with an ultimate completion date of September 22, 2025. The contract employs firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,553.36, is for the delivery of FULPHILA 6 MG/0.6 ML SYRINGE 0.6ML, a pharmaceutical product, with a performance period through March 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fulphila 6 mg/0.6 ml syringes. The contract has a firm fixed price of $1,006.88 and a completion date of June 5, 2025. This contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which...
- This is a $26,744.35 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The award is for the supply of FULPHILA 6 MG/0.6 ML SYRINGE 0.6ML, a medical product used in healthcare. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor and there are no reported subcontractors. This delivery order is part of a larger Indefinite Delivery...
- This is a $15,792.72 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FULPHILA 6 MG/0.6 ML SYRINGE 0.6ML, a medical product likely used in military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of FULPHILA 6 MG/0.6 ML SYRINGE 0.6ML, a medical commodity, with a ceiling value of $15,480.35 and a completion date of June 11, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FUZD3Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Fulphila 6 mg/0.6 mL syringes with a ceiling value of $2,834.88. This is a firm fixed-price delivery order with an ultimate completion date of May 5, 2025, to be performed at the vendor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the vendor's capability to meet federal procurement requirements in open competition. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive pharmaceutical and medical supply support to military healthcare programs worldwide, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. AmerisourceBergen Drug Corp serves as a critical vendor for the Defense Health Agency and other government healthcare systems through this flexible contracting arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 5/2/25 |